Implementation of CYP2D6 genotyping in psychiatry

Author： Loovers Harriët M   van der Weide Jan  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.9, 2009-09, pp. : 1065-1077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment

By Walko Christine M   McLeod Howard  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 691-697

Future Medicine

Access to resources Recommend Favorite

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

By Skierka Jennifer M   Walker Denise L   Peterson Sandra E   O’Kane Dennis J   Black John Logan  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 241-250

Bentham Science Publishers

Access to resources Recommend Favorite

Copy number variation and gene rearrangements in CYP2D6 genotyping using multiplex ligation-dependent probe amplification in Koreans

By Kim Juwon   Lee Soo-Youn   Lee Kyung-A  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 963-973

Future Medicine

Access to resources Recommend Favorite

CYP2D6 and the severity of suicide attempts

By Peñas-Lledó Eva M   Blasco-Fontecilla Hilario   Dorado Pedro   Vaquero-Lorenzo Concepción   Baca-García Enrique   Llerena Adrián  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 179-184

Future Medicine

Access to resources Recommend Favorite